- Home
- EEX vs IMTX Comparison
EEX vs IMTX Comparison
Compare EEX & IMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EEX
- IMTX
- Stock Information
- Founded
- EEX 2013
- IMTX N/A
- Country
- EEX United States
- IMTX Germany
- Employees
- EEX N/A
- IMTX N/A
- Industry
- EEX Advertising
- IMTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- EEX Consumer Discretionary
- IMTX Health Care
- Exchange
- EEX Nasdaq
- IMTX Nasdaq
- Market Cap
- EEX 982.4M
- IMTX 954.2M
- IPO Year
- EEX 2017
- IMTX N/A
- Fundamental
- Price
- EEX $4.80
- IMTX $6.85
- Analyst Decision
- EEX Strong Buy
- IMTX Strong Buy
- Analyst Count
- EEX 2
- IMTX 4
- Target Price
- EEX $7.90
- IMTX $16.67
- AVG Volume (30 Days)
- EEX 228.8K
- IMTX 516.6K
- Earning Date
- EEX 10-30-2024
- IMTX 11-18-2024
- Dividend Yield
- EEX 1.25%
- IMTX N/A
- EPS Growth
- EEX N/A
- IMTX N/A
- EPS
- EEX N/A
- IMTX N/A
- Revenue
- EEX $393,500,000.00
- IMTX $128,824,447.00
- Revenue This Year
- EEX $5.54
- IMTX $120.90
- Revenue Next Year
- EEX $7.75
- IMTX N/A
- P/E Ratio
- EEX N/A
- IMTX N/A
- Revenue Growth
- EEX 4.96
- IMTX 52.53
- 52 Week Low
- EEX $3.92
- IMTX $6.68
- 52 Week High
- EEX $7.05
- IMTX $13.77
- Technical
- Relative Strength Index (RSI)
- EEX 52.44
- IMTX 27.51
- Support Level
- EEX $4.60
- IMTX $6.68
- Resistance Level
- EEX $4.87
- IMTX $7.40
- Average True Range (ATR)
- EEX 0.17
- IMTX 0.33
- MACD
- EEX -0.03
- IMTX -0.03
- Stochastic Oscillator
- EEX 39.22
- IMTX 10.43
About EEX Emerald Holding Inc.
Emerald Holding Inc is an operator of B2B trade shows in the United States. The company is engaged in three complementary business lines; Connections division consists of a collection of B2B trade show franchises and other live events that provide exhibitors opportunities to engage with buyers and expand their brand's awareness in their industry, Content division consists of B2B print publications and digital media products that complement existing trade show properties, and the Commerce division which offers software-as-a-service technology that enables year-round B2B buying and selling through Elastic Suite and Bulletin platforms for use by its customers. Majority of the revenue for the company is generated from its Connections segment.
About IMTX Immatics N.V.
Immatics NV is a biotechnology company that is engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies.